Oncology & Cancer

Vascular targeted photodynamic tx aids low-risk prostate cancer

(HealthDay)—For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer in treated lobes, according to a study published in the August ...

Oncology & Cancer

Decisional regret doesn't differ by treatment in prostate cancer

(HealthDay)—For patients newly diagnosed with prostate cancer who attend a multidisciplinary clinic, decisional regret does not differ significantly between treatment groups, according to a study published online July 5 ...

Oncology & Cancer

Autologous urethral sling no benefit after prostatectomy

(HealthDay)—Placement of a retropubic urethral sling fashioned from autologous vas deferens during robotic assisted radical prostatectomy does not improve recovery of continence, according to a study published in the February ...

page 3 from 11